Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum NeutriSci International Inc V.NU.H

Alternate Symbol(s):  NRXCF

NeutriSci International Inc. (NeutriSci) is a Canada-based company, which specializes in the development, formulation, and production of products for its business-to-business (B2B) partners around the globe. The Company is focused on the market development for its nutraceutical products. Its products utilize patented form of Pterostilbene called pTeroPure. pTeroPure Pterostilbene is a form of... see more

TSXV:NU.H - Post Discussion

View:
Post by richkat on Jun 08, 2021 12:09pm

GLENN

in the words of our friend Edcando release the KRACkEN!!!
Comment by Edcando on Jun 08, 2021 12:13pm
Yes! As supportive as I am this is getting ridiculous lol. Let's get this ball rolling already 
Comment by CaptainCrunchy on Jun 08, 2021 2:18pm
Glenn really seems to have a problem with the concept of time. Coming weeks is many months, end of month is 3-6months later. Shipping it out now, is apparently not now at all. Shrug
Comment by NEWBIE65 on Jun 09, 2021 1:40am
Square balls don't roll
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities